SCHEMBL6977284

SCHEMBL6977284

CC(C(=O)O)(C(=O)c1ccccc1)N1CCOCC1

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.51
SMN1; SMN2 Q16637 5/20 0.51
TSHR P16473 4/20 0.51
MAPK1 P28482 1/20 0.51
PHGDH O43175 1/20 0.45
HPGD P15428 1/20 0.45
MAPT P10636 4/20 0.44
KMT2A Q03164 3/20 0.44
POLB P06746 1/20 0.43
LMNA P02545 1/20 0.43
GAA P10253 1/20 0.43
CYP3A4 P08684 2/20 0.43
KDM4E B2RXH2 1/20 0.43
CYP2C19 P33261 1/20 0.43
HIF1A Q16665 1/20 0.42
HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL52410 0.85 ALDH1A1 (0.68) ALDH1A1SMN1; SMN2TSHRMAPK1PHGDH
SCHEMBL7642065 0.81 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2TSHRMAPK1PHGDH
SCHEMBL9679993 0.80 SMN1; SMN2 (0.65) ALDH1A1SMN1; SMN2TSHRMAPK1HPGD
SCHEMBL10949372 0.80 ALDH1A1 (0.65) ALDH1A1SMN1; SMN2TSHRMAPK1PHGDH
SCHEMBL11546415 0.79 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2TSHRMAPK1KMT2A
SCHEMBL2223625 0.79 ALDH1A1 (0.56) ALDH1A1SMN1; SMN2TSHRMAPK1PHGDH
SCHEMBL1594213 0.79 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2TSHRMAPK1PHGDH
SCHEMBL11340621 0.77 SMN1; SMN2 (0.65) ALDH1A1SMN1; SMN2TSHRMAPK1HPGD
SCHEMBL10430205 0.76 ALDH1A1 (0.52) ALDH1A1SMN1; SMN2TSHRMAPK1PHGDH
SCHEMBL11078610 0.76 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2TSHRMAPK1PHGDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1109560-B1 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMA (US) 2003-08-27 EP disclosed
US-6525050-B1 Inhibit the enzyme aminoimidazole carboxamide ribonucleotide formyl transferase; antiproliferative agents; antitumor, antiinflammatory, antipsoriatic, and/or immunosuppressive AGOURON PHARMACEUTICALS, INC. 2003-02-25 US disclosed
EP-1109560-A4 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMA (US) 2002-04-17 EP disclosed
EP-1109560-A1 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMACEUTICALS, INC. (US) 2001-06-27 EP disclosed
WO-2000013688-A1 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMACEUTICALS, INC. (US) 2000-03-16 WO disclosed